Feeding the microbiota-gut-brain axis: diet, microbiome, and neuropsychiatry

KV Sandhu, E Sherwin, H Schellekens, C Stanton… - Translational …, 2017 - Elsevier
The microbial population residing within the human gut represents one of the most densely
populated microbial niche in the human body with growing evidence showing it playing a …

[HTML][HTML] Locus coeruleus norepinephrine in learned behavior: anatomical modularity and spatiotemporal integration in targets

V Breton-Provencher, GT Drummond… - Frontiers in Neural …, 2021 - frontiersin.org
The locus coeruleus (LC), a small brainstem nucleus, is the primary source of the
neuromodulator norepinephrine (NE) in the brain. The LC receives input from widespread …

Major depression: one brain, one disease, one set of intertwined processes

EV Filatova, MI Shadrina, PA Slominsky - Cells, 2021 - mdpi.com
Major depressive disorder (MDD) is a heterogeneous disease affecting one out of five
individuals and is the leading cause of disability worldwide. Presently, MDD is considered a …

Emotional roles of mono-aminergic neurotransmitters in major depressive disorder and anxiety disorders

Y Liu, J Zhao, W Guo - Frontiers in psychology, 2018 - frontiersin.org
A growing body of researches support a role for dysfunction of serotoninergic,
noradrenergic, and dopaminergic systems in the neurobiological processes involved in …

The importance of norepinephrine in depression

C Moret, M Briley - Neuropsychiatric disease and treatment, 2011 - Taylor & Francis
Depression is one of the most common psychological diseases with significant potential
morbidity and mortality. Although the underlying pathophysiology of depression has not …

Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders

KJ Ressler, CB Nemeroff - Depression and anxiety, 2000 - Wiley Online Library
There is abundant evidence for abnormalities of the norepinephrine (NE) and serotonin
(5HT) neurotransmitter systems in depression and anxiety disorders. The majority of …

Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment

HS Lett, JA Blumenthal, MA Babyak… - Psychosomatic …, 2004 - journals.lww.com
Objective: The present paper reviews the evidence that depression is a risk factor for the
development and progression of coronary artery disease (CAD). Methods: MEDLINE …

Monoaminergic neurotransmission: the history of the discovery of antidepressants from 1950s until today

F López-Muñoz, C Alamo - Current pharmaceutical design, 2009 - ingentaconnect.com
The 1950s saw the clinical introduction of the first two specifically antidepressant drugs:
iproniazid, a monoamine-oxidase inhibitor that had been used in the treatment of …

[HTML][HTML] Serotonin and depression: A disconnect between the advertisements and the scientific literature

JR Lacasse, J Leo - PLoS medicine, 2005 - journals.plos.org
Serotonin and Depression: A Disconnect between the Advertisements and the Scientific
Literature | PLOS Medicine Skip to main content Advertisement PLOS Medicine Browse …

Exercise and the treatment of clinical depression in adults: recent findings and future directions

AL Brosse, ES Sheets, HS Lett, JA Blumenthal - Sports medicine, 2002 - Springer
This article critically reviews the evidence that exercise is effective in treating depression in
adults. Depression is recognised as a mood state, clinical syndrome and psychiatric …